PubRank

B7-1 gene-modified tumor cell vaccines.

PubWeight™: 0.80‹?›

🔗 View Article (PMID 11249684)

Published in Curr Opin Mol Ther on February 01, 1999

Authors

S J Antonia1

Author Affiliations

1: University of South Florida, Division of Medical Oncology, H Lee Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, FL 33612, USA. antonias@moffitt.usf.edu

Articles citing this ↘

Cancer immunotherapy using Listeria monocytogenes and listerial virulence factors. Immunol Res (2008) 0.94

alpha-Galactosylceramide enhances the protective and therapeutic effects of tumor cell based vaccines for ovarian tumors. Vaccine (2008) 0.82